Financials
- Market Capitalization 1.86 B
- Employee 110
- Founded 2024
- CEO N/A
- Website www.inhibrx.com
- Headquarter Delaware, United States
- FIGI BBG01MS5Q9G3
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-10.67
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2019 | NBTX Nanobiotix S.A. - ADSs | 40.64 USD | -1.43% | +1.27% | +8.17% | +390.23% | 1.97 B USD | ||
| 2047 | IMCR Immunocore Holdings plc - American Depositary Shares | 36.32 USD | -0.82% | -0.49% | +7.46% | +8.48% | 1.87 B USD | ||
| 2050 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.69 USD | -1.39% | -5.95% | -3.40% | +96.21% | 1.85 B USD | ||
| 2052 | VIR Vir Biotechnology, Inc. - Common Stock | 10.94 USD | +1.02% | +9.07% | +25.17% | +82.94% | 1.85 B USD |